The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, 
particularly to China, Japan, and South Korea. Scientists are endeavoring to 
find antivirals specific to the virus. Several drugs such as chloroquine, 
arbidol, remdesivir, and favipiravir are currently undergoing clinical studies 
to test their efficacy and safety in the treatment of coronavirus disease 2019 
(COVID-19) in China; some promising results have been achieved thus far. This 
article summarizes agents with potential efficacy against SARS-CoV-2.
